Baxter International BAX Infusion Therapies & Technologies — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's infusion therapies & technologies — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's infusion therapies & technologies — net sales?
- Baxter International (BAX) reported infusion therapies & technologies — net sales of $981M in Q1 2026.
- How has Baxter International's infusion therapies & technologies — net sales changed year-over-year?
- Baxter International's infusion therapies & technologies — net sales decreased by 1.3% year-over-year, from $994M to $981M.
- What is the long-term trend for Baxter International's infusion therapies & technologies — net sales?
- Over 3 years (2021 to 2025), Baxter International's infusion therapies & technologies — net sales has grown at a 2.2% compound annual growth rate (CAGR), from $3.84B to $4.1B.
- What does infusion therapies & technologies — net sales mean?
- The total revenue earned from the company's infusion therapy devices, software, and related medical supplies.
- How do you interpret infusion therapies & technologies — net sales?
- An increase indicates growing demand for the company's infusion solutions or successful expansion of its installed base, while a decrease may signal competitive pressure, pricing erosion, or reduced hospital capital expenditure.
- How does infusion therapies & technologies — net sales compare across companies?
- Comparable to medical device revenue segments at peers like Becton Dickinson or ICU Medical, where performance is tied to hospital procurement cycles and the shift toward smart, connected infusion technology.